Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Sandoval

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Cell Reports|May 13, 2017
Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal CancerJesper Bertram Bramsen, Mads Heilskov Rasmussen, Halit Ongen, et al.
Journal of Hepatology|February 6, 2007
Identification of a gene-pathway associated with non-alcoholic steatohepatitisAngel Rubio, Elizabeth Guruceaga, Mercedes Vázquez-Chantada, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|June 8, 2026
Optimisation of osteosarcoma sample processing for epigenetic analysis: A comparative evaluation of formalin-fixed, paraffin-embedded samples with and without decalcification versus fresh tissueJudith González-López, Paula González-Rojo, Alejandro Berenguer-Rubio, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2016
Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancerAngel Diaz-Lagares, Ana B Crujeiras, Paula Lopez-Serra, et al.
Cell Death & Disease|November 3, 2024
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1Francisco Exposito, Miriam Redrado, Diego Serrano, et al.
Nature Communications|April 5, 2014
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effectPaula Lopez-Serra, Miguel Marcilla, Alberto Villanueva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2013
A prognostic DNA methylation signature for stage I non-small-cell lung cancerJuan Sandoval, Jesus Mendez-Gonzalez, Ernest Nadal, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Cell Reports|May 13, 2017
Molecular-Subtype-Specific Biomarkers Improve Prediction of Prognosis in Colorectal CancerJesper Bertram Bramsen, Mads Heilskov Rasmussen, Halit Ongen, et al.
Journal of Hepatology|February 6, 2007
Identification of a gene-pathway associated with non-alcoholic steatohepatitisAngel Rubio, Elizabeth Guruceaga, Mercedes Vázquez-Chantada, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|June 8, 2026
Optimisation of osteosarcoma sample processing for epigenetic analysis: A comparative evaluation of formalin-fixed, paraffin-embedded samples with and without decalcification versus fresh tissueJudith González-López, Paula González-Rojo, Alejandro Berenguer-Rubio, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2016
Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancerAngel Diaz-Lagares, Ana B Crujeiras, Paula Lopez-Serra, et al.
Cell Death & Disease|November 3, 2024
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1Francisco Exposito, Miriam Redrado, Diego Serrano, et al.
Nature Communications|April 5, 2014
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effectPaula Lopez-Serra, Miguel Marcilla, Alberto Villanueva, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2013
A prognostic DNA methylation signature for stage I non-small-cell lung cancerJuan Sandoval, Jesus Mendez-Gonzalez, Ernest Nadal, et al.
Pageof 11